{"nctId":"NCT00963599","briefTitle":"Montelukast in Seasonal Allergic Rhinitis - Fall 1999 Study (0476A-117)","startDateStruct":{"date":"1999-09"},"conditions":["Seasonal Allergic Rhinitis"],"count":907,"armGroups":[{"label":"1","type":"EXPERIMENTAL","interventionNames":["Drug: Comparator: montelukast/loratadine"]},{"label":"2","type":"EXPERIMENTAL","interventionNames":["Drug: Comparator: loratadine"]},{"label":"3","type":"EXPERIMENTAL","interventionNames":["Drug: Comparator: montelukast"]},{"label":"4","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Comparator: placebo"]}],"interventions":[{"name":"Comparator: montelukast/loratadine","otherNames":[]},{"name":"Comparator: montelukast","otherNames":[]},{"name":"Comparator: loratadine","otherNames":[]},{"name":"Comparator: placebo","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Patient has a documented history of seasonal allergic rhinitis symptoms that flare up during the study season\n* Patient is a nonsmoker\n* Patient is in good general health\n\nExclusion Criteria:\n\n* Patient is hospitalized\n* Patient is a woman who is less than 8 weeks postpartum or is breast-feeding\n* Patient intends to move or vacation away during the study\n* Patient has had any major surgery within 4 weeks of study start\n* Patient is a current or past abuser of alcohol or illicit drugs\n* Patient has been treated in an emergency room for asthma in the past month\n* Patient had an upper respiratory infection with in 3 weeks prior to study start\n* Patient has any active pulmonary disorder other than asthma","healthyVolunteers":false,"sex":"ALL","minimumAge":"15 Years","maximumAge":"85 Years","stdAges":["CHILD","ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Mean Change From Baseline in Daytime Nasal Symptoms Score","description":"Mean change from baseline in Daytime Nasal Symptoms score. Patients were asked to rate each of the 4 nasal symptoms of Congestion, Rhinorrhea, Itching, and Sneezing daily on a 4-point scale (0 (best) to 3 (worst)). The average of the 4 individual nasal symptoms scores was reported as the Daytime Nasal Symptoms Score.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.26","spread":null},{"groupId":"OG001","value":"-0.48","spread":null},{"groupId":"OG002","value":"-0.52","spread":null},{"groupId":"OG003","value":"-0.58","spread":null}]}]}]},{"type":"SECONDARY","title":"Mean Change From Baseline in Nighttime Symptoms Score","description":"Mean change from baseline in Nighttime Symptoms Score. Patients were asked to rate each symptom daily on a 4-point scale (0 (best) to 3 (worst)), and the combined score of Nasal Congestion Upon Awakening, Difficulty Going to Sleep, and Nighttime Awakenings was reported as the Nighttime Symptoms Score.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.12","spread":null},{"groupId":"OG001","value":"-0.29","spread":null},{"groupId":"OG002","value":"-0.26","spread":null},{"groupId":"OG003","value":"-0.28","spread":null}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Composite Symptoms Score (Daytime Nasal and Nighttime Symptoms)","description":"Composite Symptoms scores were computed as the average of the Daytime Nasal Symptoms scores and Nighttime Symptoms scores collected on a 4 point scale (0 (best) to 3 (worst)).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.2","spread":null},{"groupId":"OG001","value":"-0.40","spread":null},{"groupId":"OG002","value":"-0.41","spread":null},{"groupId":"OG003","value":"-0.45","spread":null}]}]}]},{"type":"SECONDARY","title":"Mean Change From Baseline in Daytime Eye Symptoms Score","description":"Mean change from baseline in Daytime Eye Symptoms scores. Patients were asked to rate each of the 4 eye symptom of tearing, itchy, red, and puffy eyes daily on a 4-point scale (0 (best) to 3 (worst)). The average of the 4 individual eye symptoms scores was reported as the Daytime Eye Symptoms Score.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.14","spread":null},{"groupId":"OG001","value":"-0.35","spread":null},{"groupId":"OG002","value":"-0.38","spread":null},{"groupId":"OG003","value":"-0.41","spread":null}]}]}]},{"type":"SECONDARY","title":"Mean Change From Baseline in Daytime Nasal Congestion Score","description":"Patients were asked to rate the nasal symptom of Congestion daily on a 4-point scale (0 (best) to 3 (worst)).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.19","spread":null},{"groupId":"OG001","value":"-0.41","spread":null},{"groupId":"OG002","value":"-0.39","spread":null},{"groupId":"OG003","value":"-0.43","spread":null}]}]}]},{"type":"SECONDARY","title":"Mean Change From Baseline in Daytime Rhinorrhea Score","description":"Patients were asked to rate the nasal symptom of Rhinorrhea daily on a 4-point scale (0 (best) to 3 (worst)).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.25","spread":null},{"groupId":"OG001","value":"-0.53","spread":null},{"groupId":"OG002","value":"-0.51","spread":null},{"groupId":"OG003","value":"-0.59","spread":null}]}]}]},{"type":"SECONDARY","title":"Mean Change From Baseline in Daytime Nasal Itching Score","description":"Patients were asked to rate the nasal symptom of Nasal Itching daily on a 4-point scale (0 (best) to 3 (worst)).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.26","spread":null},{"groupId":"OG001","value":"-0.49","spread":null},{"groupId":"OG002","value":"-0.56","spread":null},{"groupId":"OG003","value":"-0.62","spread":null}]}]}]},{"type":"SECONDARY","title":"Mean Change From Baseline in Daytime Sneezing Score","description":"Patients were asked to rate the nasal symptom of Sneezing daily on a 4-point scale (0 (best) to 3 (worst)).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.26","spread":null},{"groupId":"OG001","value":"-0.46","spread":null},{"groupId":"OG002","value":"-0.59","spread":null},{"groupId":"OG003","value":"-0.67","spread":null}]}]}]},{"type":"SECONDARY","title":"Mean Change From Baseline in Nasal Congestion Upon Awakening","description":"Patients were asked to rate the symptom of Nasal Congestion Upon Awakening daily on a 4-point scale (0 (best) to 3 (worst)).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.15","spread":null},{"groupId":"OG001","value":"-0.35","spread":null},{"groupId":"OG002","value":"-0.30","spread":null},{"groupId":"OG003","value":"-0.32","spread":null}]}]}]},{"type":"SECONDARY","title":"Patient's Global Evaluation of Allergic Rhinitis","description":"An evaluation by the patient, administered at the last visit (or upon discontinuation) using a 7-point scale, of the change in symptoms as compared to the beginning of the study. Responses were assigned numerical values from 0 (very much better) to 6 (very much worse).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2.37","spread":null},{"groupId":"OG001","value":"2.10","spread":null},{"groupId":"OG002","value":"2.00","spread":null},{"groupId":"OG003","value":"1.92","spread":null}]}]}]},{"type":"SECONDARY","title":"Physician's Global Evaluation of Allergic Rhinitis","description":"An evaluation by the physician, administered at the last visit (or upon discontinuation) using a 7-point scale, of the change in symptoms as compared to the beginning of the study. Responses were assigned numerical values from 0 (very much better) to 6 (very much worse).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2.35","spread":null},{"groupId":"OG001","value":"2.13","spread":null},{"groupId":"OG002","value":"2.05","spread":null},{"groupId":"OG003","value":"1.99","spread":null}]}]}]},{"type":"SECONDARY","title":"Mean Change From Baseline in Rhinoconjunctivitis Quality-of-Life Score","description":"Patients completed a Rhinoconjunctivitis Quality-of-Life Questionnaire, 28 questions on a 7-point scale \\[0(best) to 6(worst)\\] across 7 domains: activities, sleep, non-nose/eye symptoms, practical problems, nasal symptoms, eye symptoms, emotional. Scores per domain were averaged, then scores for the 7 domains were averaged for an overall score.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.80","spread":null},{"groupId":"OG001","value":"-1.09","spread":null},{"groupId":"OG002","value":"-1.06","spread":null},{"groupId":"OG003","value":"-1.16","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":1,"n":149},"commonTop":["Headache"]}}}